Acknowledgment to Reviewers

IF 3 3区医学 Q2 CLINICAL NEUROLOGY

Neurology-Genetics Pub Date : 2023-04-26 DOI:10.1212/nxg.0000000000200080

Stefan M. Pulst

引用次数: 0

Abstract

On behalf of all handling editors we wish to acknowledge the individuals who have completed reviews for the journal from January 2022 until February 28, 2023. The thoughtful comments and insights are essential for scientific publishing, highly appreciated, and imperative for excellence in the field of neurogenetics. We are also grateful for your cooperation in returning reviews in a timely manner. Please find the guidelines for reviewing articles on the Neurology® Genetics website at [ng.neurology.org/][1]. This page provides information on expectations of reviewers regarding confidentiality, timeliness, and reviewer conflicts of interest; it also provides instructions for formatting the comments to editors and authors to enable the most effective communication with authors. [1]: https://ng.neurology.org/

查看原文本刊更多论文

对审稿人的感谢

我们谨代表所有编辑，向在2022年1月至2023年2月28日期间完成期刊审稿的个人表示感谢。这些深思熟虑的评论和见解对科学出版至关重要，受到高度赞赏，对神经遗传学领域的卓越成就至关重要。我们也非常感谢您在及时回复评论方面的合作。请在Neurology®Genetics网站[ng.neurology.org/][1]上找到文章评审指南。本页提供有关审稿人对保密性、及时性和审稿人利益冲突的期望的信息;它还为编辑和作者提供了格式化注释的说明，以便与作者进行最有效的沟通。[1]: https://ng.neurology.org/

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurology-Genetics Medicine-Neurology (clinical)

CiteScore

6.30

自引率

3.20%

发文量

107

审稿时长

15 weeks

期刊介绍： Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. Original articles in all areas of neurogenetics will be published including rare and common genetic variation, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease-genes, and genetic variations with a putative link to diseases. This will include studies reporting on genetic disease risk and pharmacogenomics. In addition, Neurology: Genetics will publish results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems for treatment trials are welcome, including well-powered studies reporting negative results.